Hartley Dylan
OnKure Therapeutics, Inc. · Chief Scientific Officer
Hartley Dylan is listed in public filings as officer: Chief Scientific Officer. This Hartley Dylan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include OnKure Therapeutics, Inc. (OKUR). Investors use Hartley Dylan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $448k110k shares | Grant / ExerciseApr 1, 2026 | $447.7K110k shares | $4.07 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $234k45k shares | Grant / ExerciseJan 27, 2025 | $233.6K45k shares | $5.19 | -- | |
| $2.5M137.6k shares | Grant / ExerciseOct 4, 2024 | $2.5M137.6k shares | $18.20 | -- |